NGeneBio applied for Korea MFDS approval for its Comprehensive Genomic Profiling NGS panel, 'ONCOaccuPanel™' first in South Korea.

On 23rd March, NGeneBio announced that it has applied to Korea Ministry of Food and Drug Safety (MFDS) for a class III in vitro diagnostic medical device of 'ONCOaccuPanel™', Comprehensive genomic profiling products based on NGS. 'ONCOaccuPanel™' is an NGS panel developed together with Seoul Asan Medical Center and Dana-Farber Cancer Institute. NGeneBio commercialized this panel via technology transfer and it can confirm clinical effectiveness by analyzing more than 100,000 clinical samples. ONCOaccuPanel™ enables patients to receive personalized treatment by providing optimized targeting therapy information. This panel can detect MSI, TMB, and more than 300 genes that are related to 35 types of cancers such as lung, colon, gastric, and breast cancer. Besides, a dedicated software developed by NGeneBio, ‘NGeneAnalySys® helps to analyze large-scale genomic data accurately. NGeneBio also noted that ONCOaccuPanel™ is under preparation for CE-IVD marking.

NGeneBio at MEDLAB ME 2022

NGeneBio is going to participate in MEDLAB Middle East 2022, the world’s largest medical laboratory exhibition and congress, which will be held in Dubai on 24-27 January 2022. Especially this year, Medlab Middle East & Arab Health will join forces to deliver a world-class laboratory and healthcare platform. We are looking forward to meeting you live in person at Medlab Middle East. For more information on MEDLAB ME 2022, please visit https://www.medlabme.com/en/home.

NGeneBio at MEDICA 2021

NGeneBio participates in MEDICA 2021, which will be held in Atlanta on 15-18 November at the Georgia World Congress Center. (B49/Hall 1) NGeneBio has introduced our NGS-based oncology/genetic diseases kits (BRCA/HEME/SOLID/ONCO/HLA) & clinical NGS data analysis software (NGeneAnalySys, EasyHLAanalyzer) and NGenePlex™ nCoV qRT-PCR Kit against COVID-19 pandemic. For more information on MEDICA 2021, please visit https://www.medica-tradefair.com/.

NGeneBio at AACC 2021

NGeneBio is going to participate in AACC 2021, which will be held in Atlanta on 26-30 September at the Georgia World Congress Center. This year, the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo will showcase the cutting-edge science and technology shaping the future of laboratory medicine. We are looking forward to meeting you live in person at AACC. (Booth #2857) We’re going to showcase our NGS-based oncology/genetic diseases kits (BRCA/HEME/SOLID/ONCO/HLA) & clinical NGS data analysis software (NGeneAnalySys, EasyHLAanalyzer) and NGenePlex™ nCoV qRT-PCR Kit against COVID-19 pandemic. For more information on AACC 2021, please visit https://meeting.aacc.org/.

NGeneBio at MEDLAB ME 2021

NGeneBio is going to participate in MEDLAB Middle East 2021, the world’s largest medical laboratory exhibition and congress, which will be held in Dubai on 21-24 June 2021 at the Dubai World Trade Centre. Especially this year, Medlab Middle East & Arab Health will join forces to deliver a world-class laboratory and healthcare platform. We are looking forward to meeting you live in person at Medlab Middle East. For more information on MEDLAB ME 2021, please visit https://www.medlabme.com/en/home.

NGeneBio at Conference of The Korean Society of Pathologists

NGeneBio is going to participate as an exhibitor in the Spring Academic Conference of the Korean Society of Pathologists from May 13 to 14, 2021. At this online conference, ONCOaccuPanel, NGeneBio’s comprehensive solid tumor oncology NGS test, will be displayed as a major product. ONCOaccuPanel is a solid cancer NGS panel that has been analyzed more than 7,000 cancer patient clinical samples in Korea. It covers SNVs, INDELs, CNV, SV, MSI and TMB, in single test. For more information, please visit the ‘ONCOaccuPanel’ page in the top menu ‘Products’.

NGeneBio at KSLM 2021

NGeneBio participated as an exhibitionist at the Spring Symposium of the Korean Society for Laboratory Medicine (KSLM 2021), which took place from April 1 to 2, 2021 under the slogan ‘Laboratory Medicine Beyond Pandemic’.NGeneBio displayed BRCAaccuTest® PLUS, HEMEaccuTest™, and ONCOaccuPanel™, which are kits for diagnosing cancers using NGS (Next Generation Sequencing) technology.

2020 MEDLAB Dubai

NGeneBio is going to participate in MEDLAB Middle East (MEDLAB ME) 2020 with a newly designed booth, which will be held in Dubai, the United Arab Emirates on 3-6 February 2020. MEDLAB ME is the flagship exhibition and congress of the global MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences.

2019 MEDICA, Germany

2019 MEDICA, Germany Participate in MEDICA 2019, the world’s largest medical exhibition organized by Messe Düsseldorf GmbH. It will be held in Düsseldorf, Germany from November 18-21, 2019.NGeneBio has introduced BRCAaccuTest™, HEMEaccuTest™, SOLIDaccuTest™ and analysis software, which are kits for diagnosing caners using NGS (Next Generation Sequencing) technology. This year, the new ONCOaccuPanel and HLAaccuTest™ will be introduced. In addition, there are also A-STR (16 plex & 9 plex) and Y-STR that can confirm paternity, forensics, and chimerism by analyzing DNA profiles using Sanger sequencing.

AACC 2019 ANAHEIM

August 4–8, 2019Anaheim Convention Center Anaheim, California USA AACC (AMERICAN ASSOCIATION for CLINICAL CHEMISTRY) Annual Scientific Meeting & Clinical Lab Expo is a worldwide outstanding event showcases the cutting-edge science and technology shaping the future of laboratory medicine including molecular diagnostics. The 71st AACC Clinical Lab Expo will be held in Anaheim, California, August 4-8, 2019. NGeneBio will participate in AACC Clinical Lab Expo introducing next generation sequencing (NGS)-based clinical diagnostic products, clinical NGS analysis software and short tandem repeat (STR) genetic testing products.Pleases visit us at booth #674. For more information on AACC 2019, please visit https://www.2019aacc.org/

2019 MEDLAB, Dubai

MEDLAB Dubai, 2018 – NGeneBio at Z6.A31

Booth Stand No. Z6.A31https://www.medlabme.com/en/overview/show-information.html 600 EXHIBITORS 40 EXHIBITING COUNTRIES 16 COUNTRY PAVILIONS 25,000 ATTENDEES 6,500 DELEGATES 17 CONFERENCES MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US.As the largest attended laboratory expo worldwide, MEDLAB stems from 15 years of growth alongside the MENA region’s largest healthcare gathering, Arab Health. Moving into its 2nd year as a stand-alone show given its vigorous growth, this annual laboratory meeting is set to welcome over 600 exhibitors and more than 25,000 attendees from 129+ countries.Now featuring Obs-Gyne Exhibition, MEDLAB is the all encompassing event for every specialism within the laboratory management and diagnostics spectrum.Accompanied by 17 multi-disciplinary CME-accredited conferences, the Congress provides education, best practise and the chance to learn, meet and network with leading laboratorians from across the globe, as delivered by over 128 thought-leaders. View the congress overview. MEDLAB will take place from 5 – 8 February 2018 at the Dubai International Convention & Exhibition Center, Dubai, UAE.